Opthea Limited (AU:OPT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Opthea Limited gears up for a pivotal moment with anticipated Phase 3 data readouts in 2025, bolstering its leadership by appointing Parisa Zamiri as Chief Medical Officer, Tom Reilly as Chief Financial Officer, and Anand Sundaram as Vice President Marketing. These strategic hires aim to reinforce the company’s expertise in retinal diseases and its commercial readiness ahead of regulatory submissions. Dr. Zamiri brings a wealth of experience in ophthalmology, while Reilly and Sundaram provide strong financial leadership and marketing acumen, respectively.
For further insights into AU:OPT stock, check out TipRanks’ Stock Analysis page.